Home > Healthcare > Pharmaceuticals > Finished Drug Form > neuroprotection market
Get a free sample of Neuroprotection Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Neuroprotection Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The neuroprotection industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.
Some of the eminent market participants operating in the neuroprotection industry include:
Neuroprotection industry size was USD 38.3 billion in 2023 and is estimated to exceed USD 70.7 billion by 2032 driven by rising need for safeguarding neuron structure and function in the brain and nervous system.
Neuroprotection market from the oral route of administration segment recorded USD 24.9 billion in valuation in 2023, due to advancements in pharmaceutical formulations to improve efficacy, bioavailability, and stability of oral neuroprotection agents.
The antioxidants product segment is estimated to reach USD 14.7 billion by 2032, led by ongoing research underscoring the potential for slowing disease progression and preserving cognitive function.
North America neuroprotection industry held 40.6% of the market revenue share in 2023 and will see expansion till 2032 owing to the presence of advanced healthcare infrastructure and research facilities.